Butylphthalide

Generic Name
Butylphthalide
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C12H14O2
CAS Number
6066-49-5
Unique Ingredient Identifier
822Q956KGM
Background

Butylphthalide has been used in trials studying the prevention of Restenosis.

Indication

⑴用于治疗轻、中度急性缺血性脑卒中及急性缺血性脑卒中患者神经功能缺损的改善。

⑵用于非痴呆型血管性认知障碍【美国FDA未批准；《中国痴呆与认知障碍诊治指南2015》；中国卒中学会《卒中后认知障碍管理专家共识2017》】。

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

First Posted Date
2024-11-26
Last Posted Date
2024-11-26
Lead Sponsor
Xiangya Hospital of Central South University
Target Recruit Count
40
Registration Number
NCT06704685

Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment

First Posted Date
2024-07-18
Last Posted Date
2024-07-18
Lead Sponsor
First Hospital of China Medical University
Target Recruit Count
100
Registration Number
NCT06508671

Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery

First Posted Date
2024-03-26
Last Posted Date
2024-03-26
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Target Recruit Count
140
Registration Number
NCT06331494
Locations
🇨🇳

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

First Posted Date
2021-10-05
Last Posted Date
2024-04-09
Lead Sponsor
Qianfoshan Hospital
Target Recruit Count
300
Registration Number
NCT05068349
Locations
🇨🇳

Shandong Provincial Qianfoshan Hospital, Jinan, Shandong Provincial, China

Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment

First Posted Date
2018-05-29
Last Posted Date
2022-08-05
Lead Sponsor
Beijing Tiantan Hospital
Target Recruit Count
1216
Registration Number
NCT03539445
Locations
🇨🇳

Beijing Tiantan Hospital, Beijing, Beijing, China

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

First Posted Date
2016-03-17
Last Posted Date
2020-02-12
Lead Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Target Recruit Count
92
Registration Number
NCT02711683
Locations
🇨🇳

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke

First Posted Date
2014-05-29
Last Posted Date
2020-08-24
Lead Sponsor
Shanghai 6th People's Hospital
Target Recruit Count
84
Registration Number
NCT02149875
Locations
🇨🇳

Shanghai Sixth People's Hospital, Shanghai, China

Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting

Phase 3
Completed
Conditions
Restenosis
Interventions
Drug: Butylphthalide
Drug: Placebo
First Posted Date
2011-07-29
Last Posted Date
2015-10-26
Lead Sponsor
Jinling Hospital, China
Target Recruit Count
100
Registration Number
NCT01405248
Locations
🇨🇳

Department of Neurology ;Jinling Hospital, Nanjing,, Jiangsu, China

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy